Key Takeaways
- • Carlyle Group is preparing a potential $400 million IPO of Highway Roop Precision Technologies, its Indian auto-parts platform, with listing targeted for the first half of 2027.
- • The offering will be underwritten by Kotak Mahindra Capital, JM Financial, Goldman Sachs, and Nomura, and will include both newly issued and existing shares.
- • Highway Roop Precision Technologies was formed in 2025 after Carlyle acquired controlling stakes in Highway Industries and Roop Automotives, combining them into a platform with annual production capacity of 38 million steering yokes across 200+ variants.
- • Carlyle is simultaneously preparing an estimated $400 million IPO for Knack RCM, its Indian healthcare revenue-cycle management business, signaling an accelerated exit strategy from its Indian portfolio.
- • Indian IPO market momentum supports the planned listings, with $10.4 billion raised year-to-date in 2026 versus $22.3 billion for all of 2025, indicating renewed capital markets activity.
Summary
Highway Roop Precision Technologies represents Carlyle's consolidation play in the Indian auto-component sector. The platform was established in 2025 following Carlyle's acquisition of controlling interests in two established manufacturers: Highway Industries and Roop Automotives. The combined entity has positioned itself as a significant producer of hot-forged steering yokes, with current annual production capacity exceeding 38 million units across more than 200 variants—a scale that reflects considerable market presence within India's automotive supply chain.
The timing of this IPO reflects broader momentum in India's capital markets. Year-to-date in 2026, Indian companies have raised approximately $10.4 billion through public offerings, demonstrating renewed investor appetite. While this trails the $22.3 billion raised across all of 2025, the trajectory suggests improving conditions for equity issuances, particularly in industrials and manufacturing.
The Highway Roop listing is not Carlyle's sole Indian exit under preparation. The buyout firm has simultaneously appointed advisers to explore an IPO for Knack RCM, its healthcare revenue-cycle management business, which similarly targets approximately $400 million in proceeds. This dual-track approach underscores Carlyle's strategic intent to crystallize returns from its Indian portfolio as market conditions permit, leveraging improved IPO market dynamics to optimize exit timing and valuation realization.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.